Discover
BKYI
BIO-key International, Inc.
4.50
361 x 4.27
354 x 4.50
bid
ask
-
0.01
0.22%
358 @ 04:00 PM
3.17 -1.33 (29.57%)
| Ytd | -16.67% | |
| 1y | -45.78% |
4.26
day range
4.53
3.10
52 week range
19.70
| Open | 4.51 | Prev Close | 4.51 | Low | 4.26 | High | 4.53 | Mkt Cap | 4.88M |
| Vol | 1.97K | Avg Vol | 22.00K | EPS | -9.40 | P/E | N/A | Forward P/E | -0.69 |
| Beta | 0.24 | Short Ratio | 0.16 | Inst. Own | 9.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 4.65 | 200-d Avg | 6.35 | 1yr Est | 3.00 |
| Income Statement | |||
| Total Revenue | 1.55M | ||
| Revenues (USD) | 1.55M | ||
| Cost of Revenue | 357.99K | ||
| Gross Profit | 1.19M | ||
| Operating Expenses | 2.08M | ||
| Research and Development Expense | 683.62K | ||
| Selling, General and Administrative Expense | 1.40M | ||
| Operating Income | -892.19K | ||
| Interest Expense | 13.17K | ||
| Net Income | -964.85K | ||
| Net Income Common Stock | -964.85K | ||
| Net Income Common Stock (USD) | -964.85K | ||
| Consolidated Income | -964.85K | ||
| Earnings per Basic Share | -1.50 | ||
| Earnings per Basic Share (USD) | -1.50 | ||
| Earnings per Diluted Share | -1.50 | ||
| Earning Before Interest & Taxes (EBIT) | -951.67K | ||
| Earning Before Interest & Taxes (USD) | -951.67K | ||
| Weighted Average Shares | 658.75K | ||
| Weighted Average Shares Diluted | 658.75K | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.04M | ||
| Cash and Equivalents (USD) | 2.04M | ||
| Investments | 5.00M | ||
| Investments Non-Current | 5.00M | ||
| Trade and Non-Trade Receivables | 959.50K | ||
| Current Assets | 3.75M | ||
| Property, Plant & Equipment Net | 136.99K | ||
| Total Assets | 10.11M | ||
| Debt Current | 434.47K | ||
| Total Debt | 1.46M | ||
| Current Liabilities | 2.96M | ||
| Debt Non-Current | 1.03M | ||
| Total Liabilities | 4.07M | ||
| Accumulated Retained Earnings (Deficit) | -132.18M | ||
| Accumulated Other Comprehensive Income | 40.99K | ||
| Shareholders Equity | 6.05M | ||
| Shareholders Equity (USD) | 6.05M | ||
| Assets Non-Current | 6.37M | ||
| Total Debt (USD) | 1.46M | ||
| Deferred Revenue | 734.77K | ||
| Goodwill and Intangible Assets | 1.22M | ||
| Inventory | 394.18K | ||
| Liabilities Non-Current | 1.10M | ||
| Trade and Non-Trade Payables | 655.65K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 77.60K | ||
| Net Cash Flow from Financing | 962.51K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -235.49K | ||
| Capital Expenditure | -1.32K | ||
| Issuance (Repayment) of Debt Securities | 962.51K | ||
| Net Cash Flow from Investing | -1.32K | ||
| Net Cash Flow from Operations | -1.12M | ||
| Effect of Exchange Rate Changes on Cash | -73.91K | ||
| Share Based Compensation | 31.66K | ||